Akira Kawata

Cyclic Hexapeptide Endothelin Receptor Antagonists Highly Potent for Both Receptor Subtypes ETA and ETB

Takashi Kikuchi, Tetsuya Ohtaki, Akira Kawata et al. · Biochemical and Biophysical Research Communications · 1994 · 48 citations

Molecular Pharmacology, Functional Selectivity, Medicine +8

Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.

Yosuke Masuda, Tsukasa Sugo, Takao Kikuchi et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 30 citations

Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.

Akira Kawata, M. Yoshida, M. Okazaki et al. · PubMed · 1994 · 29 citations

Cell Therapy, Immunology, Pathology +18

Long‐term outcome in 306 males with alcoholism

Tetsuro Noda, Hiroyuki Imamichi, Akira Kawata et al. · Psychiatry and Clinical Neurosciences · 2001 · 27 citations · Full text

Substance Use, Mental Health, Substance Use Disorders +20

Matrix Metalloproteinase-2 in Dentin Matrix Mineralization

Masanori Satoyoshi, Akira Kawata, Tadahiko Koizumi et al. · Journal of Endodontics · 2001 · 26 citations